These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9580241)

  • 1. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.
    Castellanos MC; Muñoz C; Montoya MC; Lara-Pezzi E; López-Cabrera M; de Landázuri MO
    J Immunol; 1997 Dec; 159(11):5463-73. PubMed ID: 9580241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cis-acting elements regulate the expression of the early T cell activation antigen CD69.
    Castellanos Mdel C; López-Giral S; López-Cabrera M; de Landázuri MO
    Eur J Immunol; 2002 Nov; 32(11):3108-17. PubMed ID: 12385031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max.
    Kirch HC; Flaswinkel S; Rumpf H; Brockmann D; Esche H
    Oncogene; 1999 Apr; 18(17):2728-38. PubMed ID: 10348347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL; Iacobelli M
    J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of interleukin-2 gene expression by CD69-generated signals.
    D'Ambrosio D; Trotta R; Vacca A; Frati L; Santoni A; Gulino A; Testi R
    Eur J Immunol; 1993 Nov; 23(11):2993-7. PubMed ID: 8223876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1.
    Tugores A; Alonso MA; Sánchez-Madrid F; de Landázuri MO
    J Immunol; 1992 Apr; 148(7):2300-6. PubMed ID: 1545132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the AP-1 sites in the IL-2 promoter.
    Jain J; Valge-Archer VE; Rao A
    J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
    Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
    Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription.
    Petrak D; Memon SA; Birrer MJ; Ashwell JD; Zacharchuk CM
    J Immunol; 1994 Sep; 153(5):2046-51. PubMed ID: 8051409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of peripheral blood T cell activation by human endothelial cells. Enhanced IL-2 transcription correlates with increased c-fos synthesis and increased Fos content of AP-1.
    Hughes CC; Pober JS
    J Immunol; 1993 Apr; 150(8 Pt 1):3148-60. PubMed ID: 8468462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
    Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
    Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells.
    Mondino A; Whaley CD; DeSilva DR; Li W; Jenkins MK; Mueller DL
    J Immunol; 1996 Sep; 157(5):2048-57. PubMed ID: 8757326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
    J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.